Catalyst Wire Dossier Catalyst Wire Dossier

Erwinase

L-asparaginase from Erwinia chrysanthemi
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Erwinase, covering 2014-09-11 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia

See pricing